Table 2.
Coefficient | ME | P-value | Lower 95% CI | Upper 95% CI | |
---|---|---|---|---|---|
Cost model | (€) | ||||
Disease duration | 0.053 | 1075* | 0.004 | 0.017 | 0.088 |
Change per unit increase in DAS28 | 0.157 | 360* | 0.004 | 0.050 | 0.264 |
Age | 0.005 | NR | 0.364 | −0.006 | 0.017 |
Sex (female) | −0.171 | NR | 0.268 | −0.472 | 0.131 |
BMI | −0.001 | NR | 0.967 | −0.041 | 0.039 |
Constant | 7.645 | NR | 0.000 | 6.740 | 8.550 |
Overall work impairment model | (%) | ||||
Change per unit increase in DAS28 | NR | 4.7* | 0.011 | 1.1 | 8.4 |
Mild vs no pain | NR | 33.3* | 0.022 | 4.9 | 61.8 |
Moderate vs no pain | NR | 43.4* | 0.004 | 13.6 | 73.2 |
Severe vs no pain | NR | 45.0* | 0.009 | 11.2 | 78.9 |
Costs are formatted as follows: cost (subgroup sample size).
ME: marginal effect; NR: not reported.
P < 0.05.